Skip to main content
. 2021 Aug 12;24(1):64–77. doi: 10.1093/neuonc/noab197

Fig. 1.

Fig. 1

Summary of the experimental design and platform used for assessing drug distribution and response in patient-derived xenograft (PDX) models and clinical trial specimens resected from contrast-enhancing (CE) and non–contrast-enhancing (NCE) regions.